Sep 18, 2025 11:02AM
Aug 1, 2025 08:25AM
Jun 24, 2025 06:51AM
Jun 23, 2025 07:30AM
Jun 23, 2025 07:30AM
Mar 6, 2025 09:04AM
Mar 3, 2025 08:26AM Grabar Law Office is Investigating Claims on Behalf of Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); Mercury Systems, Inc. (NASDAQ: MRCY); Methode Electronics, Inc. (NYSE: MEI
Feb 24, 2025 05:14PM
Jun 7, 2024 09:00PM
Jun 3, 2024 09:00PM
May 29, 2024 09:00PM
May 25, 2024 09:00PM
May 21, 2024 09:00PM
May 16, 2024 10:00PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against HireRight, Checkpoint, Ocugen, and Sonder Innovations and Encourages Investors to Contact the Firm
May 12, 2024 09:00PM
May 7, 2024 09:00PM
May 2, 2024 09:00PM
Apr 28, 2024 09:00PM
Apr 23, 2024 09:00PM
Apr 19, 2024 09:00PM
Jan 9, 2023 06:00AM Ocugen (OCGN) Reports Positive Phase 2/3 Top-Line Data for COVAXIN
Jan 9, 2023 06:00AM
Jan 9, 2023 06:00AM
Aug 5, 2022 07:30AM
May 24, 2022 07:11AM
May 24, 2022 07:11AM
May 23, 2022 09:19AM
May 23, 2022 06:36AM Ocugen (OCGN) Announces FDA Removes Clinical Hold on Phase 2/3 Clinical Trial for COVAXIN
May 23, 2022 06:36AM
May 6, 2022 06:35AM
May 6, 2022 06:33AM
Apr 18, 2022 07:11AM
Apr 18, 2022 07:11AM
Feb 25, 2022 07:31AM
Feb 22, 2022 09:20AM Pre-Open Stock Movers 02/22: (MTOR) (VEV) (HMHC) Higher; (FIXX) (KPTI) (YNDX) Lower (more...)
Feb 22, 2022 05:46AM
Feb 18, 2022 05:25PM
Feb 15, 2022 07:25AM
Jan 27, 2022 09:25AM
Jan 27, 2022 09:25AM
Jan 12, 2022 09:29AM
Jan 12, 2022 06:44AM Ocugen's (OCGN) COVAXIN Booster Shown to Neutralize Both Omicron and Delta Variants
Jan 12, 2022 06:43AM
Jan 10, 2022 09:26AM
Jan 10, 2022 06:25AM
Jan 8, 2022 06:27PM
Dec 30, 2021 10:01AM
Dec 30, 2021 09:59AM
Dec 15, 2021 06:46AM Ocugen (OCGN) Reports New Data Suggesting COVAXIN Vaccine Candidate Generates Robust Immune Memory to COVID-19 and Variants of Concern for At Least Six Months After Vaccination
Dec 15, 2021 06:46AM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All